Carboplatin and Paclitaxel Plus ASA404 as First-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Multicenter Single Arm Phase II Trial (SAKK 15/08)Martin Früh, Miklos Pless, Alfred Zippelius et al.|Clinical Lung Cancer|2012Cited by 23
2500 Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after first-line docetaxel (Doc) therapy: Results of a multicenter randomized double-blind placebo-controlled phase III trial (SAKK 08/11)Richard Cathomas, Silke Gillessen, S. Crabb et al.|European Journal of Cancer|2015Cited by 0